EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Innovations in Aptamer Technology: SELEX To Intelligent Molecular Engineering and Clinical Translation

Arshad Mehmood iD, Miraj Ud Din, Sunil Kumar Shah, Muhammad Faizan Munawer, Munazzah Marryum, Hui Jiang, Xiaohui Liu, Xuemei Wang

The FASEB Journal · 31.08.2026 · 40 (16)

DOI: 10.1096/fj.202603070rr ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, online erschienen am 20.08.2026. Verfasst von Arshad Mehmood und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: SELEX Aptamer Technique, Aptamers, Nucleotide, Artificial Intelligence, Translational Research, Biomedical. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aptamers—short, single‐stranded nucleic acids capable of folding into complex three‐dimensional structures—have evolved from biochemical curiosities into programmable molecular interfaces with expanding diagnostic and therapeutic relevance. Through systematic evolution of ligands by exponential enrichment (SELEX), aptamers exploit the structural plasticity of nucleic acids to achieve high‐affinity and high‐specificity target recognition. Innovations in chemical modification, high‐throughput sequencing, microfluidics, nanotechnology, and artificial intelligence (AI) have redefined aptamer discovery and translational potential. Aptamers transition from antibody alternatives to programmable molecular systems capable of sensing, computation, and controlled actuation in biological environments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SELEX Aptamer TechniqueAptamers, NucleotideArtificial IntelligenceTranslational Research, BiomedicalHumansNanotechnologyAnimals

Stichwörter der Autor:innen

SELEXaptamersaptamer‐based diagnosticsartificial intelligence‐guided molecular designnucleic acid therapeuticsprogrammable molecular interfaces

Substanzen

Aptamers, Nucleotide

Autor:innen und Institutionen

  • State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.

ORCID-Profile: Arshad Mehmood

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • National Natural Science Foundation of China

Zitieren

APA

Mehmood, A., Din, M. U., Shah, S. K., Munawer, M. F., Marryum, M., Jiang, H., Liu, X., & Wang, X. (2026). Innovations in Aptamer Technology: SELEX To Intelligent Molecular Engineering and Clinical Translation. The FASEB Journal, 40(16). https://doi.org/10.1096/fj.202603070rr

Vancouver

Mehmood A, Din MU, Shah SK, Munawer MF, Marryum M, Jiang H, et al. Innovations in Aptamer Technology: SELEX To Intelligent Molecular Engineering and Clinical Translation. The FASEB Journal. 2026;40(16). doi:10.1096/fj.202603070rr

BibTeX
@article{Mehmood2026,
  author = {Mehmood, Arshad and Din, Miraj Ud and Shah, Sunil Kumar and Munawer, Muhammad Faizan and Marryum, Munazzah and Jiang, Hui and Liu, Xiaohui and Wang, Xuemei},
  title = {Innovations in Aptamer Technology: SELEX To Intelligent Molecular Engineering and Clinical Translation},
  journal = {The FASEB Journal},
  year = {2026},
  volume = {40},
  number = {16},
  doi = {10.1096/fj.202603070rr}
}
Kostenlos starten →